Author:
Hou Jinning,Jin Kang,Li Jin,Jiang Yuqi,Li Xiaoyang,Wang Xuejian,Huang Yongxue,Zhang Yingjie,Xu Wenfang
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 4a′-Hydroxy-3′,3′,5,6′,6′,7-hexamethyl-3′,4′,4a′,6′,7′,9a′-hexahydrospiro[indole-3,9′-xanthene]-1′,2,8′(1H,2′H,5′H)-trione;Molbank;2023-09-08
2. Triethylammonium 2-(3-Hydroxy-2-oxoindolin-3-yl)-5,5-dimethyl-3-oxocyclohex-1-en-1-olate;Molbank;2023-02-15
3. Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives;Journal of Medicinal Chemistry;2022-10-07
4. Discovery of Novel Tetrahydro-β-carboline Containing Aminopeptidase N Inhibitors as Cancer Chemosensitizers;Frontiers in Oncology;2022-05-23
5. Isatin‐3‐acylhydrazones with Enhanced Lipophilicity: Synthesis, Antimicrobial Activity Evaluation and the Influence on Hemostasis System;Chemistry & Biodiversity;2022-01-13